WINDROSE HEALTH INVESTORS
320 Park AveNew York, NY 10022
Website: windrose.com
Firm Size
- Assets Under Management (AUM):$1.8 Billion
- Employees:20
- Firm Type:Private Equity
- Focus Areas:
Services
Healthcare
Description
WindRose Health Investors, LLC is a private equity firm based in New York, New York. The company specializes in investing in healthcare companies, particularly those in the healthcare services and medical devices sectors. WindRose aims to partner with strong management teams and provide them with the necessary resources and expertise to help their portfolio companies achieve sustainable growth. They typically invest in companies with revenues between $20 million and $100 million. Overall, WindRose Health Investors is dedicated to supporting the growth and development of innovative healthcare companies in order to improve patient outcomes and create value for their investors.Latest News
Powered by
Aug 10, 2023: WindRose Portfolio Company Healthmap Raises $100 Million to Continue Fighting Kidney Disease
WindRose Health Investors, LLC ("WindRose"), a leading healthcare-focused private equity firm, announced that its portfolio company, Healthmap Solutions, Inc. ("Healthmap"), has raised $100 million to support the ongoing expansion of its business. Healthmap is a national population health management company focused on kidney disease. The company has grown rapidly and is currently contracted with its health plan customers to serve over 160,000 individuals.
Jul 12, 2023: WindRose Health Investors Closes Fund VI at Over $1.4 Billion
WindRose Health Investors, LLC ("WindRose"), a leading healthcare-focused private equity firm, has closed its sixth fund, WindRose Health Investors VI, L.P. ("Fund VI") with over $1.4 billion in limited partner and general partner commitments. The fund closed at its hard cap and significantly exceeded the size of its $705 million predecessor fund.